EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins

Xinrui Yang iD, Jian Jin, Siyi Huang, Peng Qiu, Ruihua Wang, Kaichuang Ye, Xinwu Lu

Vascular · 2025

DOI: 10.1177/17085381241249288 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Vascular, 2025. Verfasst von Xinrui Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shaihai JiaoTong Univeresity, Shanghai, China. Hauptthemen laut MEDLINE: Varicose Veins, Laser Therapy, Postoperative Pain, Edema. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Program of 9th People’s Hospital, Shanghai Science and Technology Innovation Action Plan, Shandong Luye Pharmaceutical Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endovenous interventions and minimally invasive procedures are effective in the management of varicose veins. However, they can cause postoperative discomfort.

Objective

To evaluate the clinical efficacy of sodium aescinate (SA) in improving edema, pain, vein-specific symptoms, and quality of life in patients following endovenous laser ablation (EVLA) for varicose veins.

Methods

In this single-center randomized controlled trial (RCT), patients were allocated into two groups: in Group A, 60 mg SA was administered twice daily for 20 days, and in Group B (control), no venoactive drug was prescribed. The Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification system for chronic venous disorders was used to assess the varicose veins. The circumferences of the calf and ankle were recorded for evaluating edema. The 10-point Visual Analog Scale (VAS), Venous Clinical Severity Score (VCSS), and Aberdeen Varicose Veins Questionnaire (AVVQ) were used to measure the pain intensity, overall varicose vein severity, and patient’s quality of life, respectively.

Results

The study included 87 patients (mean age, 59.9 ± 10.7 years; 54 men) with CEAP class C2–C5 varicose veins who underwent EVLA and phlebectomy or foam sclerotherapy. The calf circumference recovered quicker in Group A than in Group B by days 10, 21, and 30 (difference from baseline was 1.04 ± 0.35 vs 2.39 ± 1.15 [ p < .001], 0.48 ± 0.42 vs1.73 ± 1.00 [ p < .001], and 0.18 ± 0.64 vs 0.82 ± 0.96 [ p < .001], respectively). The ankle circumference recovered quicker in Group A than in Group B by days 10 and 21 (the difference from baseline was 1.37 ± 0.52 vs 2.36 ± 0.93 [ p < .001] and 0.58 ± 0.60 vs 1.14 ± 0.88 [ p = .002], respectively). Pain relief was achieved quicker in Group A than in Group B (0.257 ± 1.097 [ p = .0863] vs 0.506 ± 1.250 [ p = .0168] by day 21). There were no significant differences in the VCSS and AVVQ scores between both groups. There were no drug-related adverse effects.

Conclusions

SA, in combination with compression therapy, can relieve edema and alleviate pain in patients following EVLA for varicose veins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Varicose VeinsLaser TherapyPostoperative PainEdemaEndovascular ProceduresHumansMaleMiddle AgedFemaleTreatment OutcomeQuality of LifeAgedTime FactorsPain MeasurementAdultSeverity of Illness Index

Stichwörter der Autor:innen

Varicose veinsedemaendovenous interventionpainsodium aescinate

Autor:innen und Institutionen

  • Department of Vascular Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shaihai JiaoTong Univeresity, Shanghai, China.
  • Vascular Center of Shanghai JiaoTong University, Shanghai JiaoTong University, Shanghai, China.
  • Drug Clinical Trial Institution, Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.

ORCID-Profile: Xinrui Yang

Förderung

  • Fundamental Research Program of 9th People’s Hospital
  • Shanghai Science and Technology Innovation Action Plan
  • Shandong Luye Pharmaceutical Co., Ltd

Zitieren

APA

Yang, X., Jin, J., Huang, S., Qiu, P., Wang, R., Ye, K., & Lu, X. (2025). Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins. Vascular. https://doi.org/10.1177/17085381241249288

Vancouver

Yang X, Jin J, Huang S, Qiu P, Wang R, Ye K, et al. Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins. Vascular. 2025. doi:10.1177/17085381241249288

BibTeX
@article{Yang2025,
  author = {Yang, Xinrui and Jin, Jian and Huang, Siyi and Qiu, Peng and Wang, Ruihua and Ye, Kaichuang and Lu, Xinwu},
  title = {Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins},
  journal = {Vascular},
  year = {2025},
  doi = {10.1177/17085381241249288}
}
Kostenlos starten →